The authors also show that PRDX2 was not able to bind to PTEN, which is in agreement with our results, demonstrating that PRDX2 up-regulation is not able to impede the enhanced AKT phosphorylation observed upon depletion of ANXA2 in cancer cells. Here, AKT1 is linked to cancer.